Testing lab-grown tumor samples to predict immunotherapy response in lung cancer

Researchers are testing whether they can grow tiny samples of your tumor in the laboratory and use them to predict whether your body will respond well to immunotherapy — the standard treatment for advanced lung cancer. By understanding your tumor's behavior in advance, doctors hope to identify which patients will benefit most from this medication and which might need a different approach.

Many people with advanced lung cancer receive immunotherapy, but a large number don't respond to it or stop responding over time. This study exists to find a way to predict who will benefit before treatment starts, so doctors can personalize care and explore new treatment combinations.